Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept

Marina Ramirez-Alvarado, David R. Barnidge, David L. Murray, Angela Dispenzieri, Marta Marin-Argany, Christopher J. Dick, Shawna A. Cooper, Samih H. Nasr, Christopher J. Ward, Surendra Dasari, Víctor H. Jiménez-Zepeda, Nelson Leung

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Immunoglobulin light chain (AL) amyloidosis is a fatal complication of B-cell proliferation secondary to deposition of amyloid fibrils in various organs. Urinary exosomes (UEX) are the smallest of the microvesicles excreted in the urine. Previously, we found UEX of patients with AL amyloidosis contained immunoglobulin light chain (LC) oligomers that patients with multiple myeloma did not have. To further explore the role of the LC oligomers, UEX was isolated from an AL amyloidosis patient with progressive renal disease despite achieving a complete response. LC oligomers were identified. Mass spectrometry (MS) of the UEX and serum identified two monoclonal lambda LCs. Proteomics of the trypsin digested amyloid fragments in the kidney by laser microdissection and MS analysis identified a λ6 LC. The cDNA from plasma cell clone was from the IGLV- 6-57 family and it matched the amino acid sequences of the amyloid peptides. The predicted mass of the peptide product of the cDNA matched the mass of one of the two LCs identified in the UEX and serum. UEX combined with MS were able to identify 2 monoclonal lambda LCs that current clinical methods could not. It also identified the amyloidogenic LC which holds potential for response assessment in the future.

Original languageEnglish (US)
Pages (from-to)536-541
Number of pages6
JournalAmerican Journal of Hematology
Volume92
Issue number6
DOIs
StatePublished - Jun 1 2017

Fingerprint

Exosomes
Amyloidosis
Kidney
Amyloid
Immunoglobulin Light Chains
Light
Mass Spectrometry
Complementary DNA
Microdissection
Peptides
Plasma Cells
Serum
Multiple Myeloma
Proteomics
Trypsin
Amino Acid Sequence
Lasers
B-Lymphocytes
Clone Cells
Cell Proliferation

ASJC Scopus subject areas

  • Hematology

Cite this

Assessment of renal response with urinary exosomes in patients with AL amyloidosis : A proof of concept. / Ramirez-Alvarado, Marina; Barnidge, David R.; Murray, David L.; Dispenzieri, Angela; Marin-Argany, Marta; Dick, Christopher J.; Cooper, Shawna A.; Nasr, Samih H.; Ward, Christopher J.; Dasari, Surendra; Jiménez-Zepeda, Víctor H.; Leung, Nelson.

In: American Journal of Hematology, Vol. 92, No. 6, 01.06.2017, p. 536-541.

Research output: Contribution to journalArticle

Ramirez-Alvarado, M, Barnidge, DR, Murray, DL, Dispenzieri, A, Marin-Argany, M, Dick, CJ, Cooper, SA, Nasr, SH, Ward, CJ, Dasari, S, Jiménez-Zepeda, VH & Leung, N 2017, 'Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept', American Journal of Hematology, vol. 92, no. 6, pp. 536-541. https://doi.org/10.1002/ajh.24717
Ramirez-Alvarado, Marina ; Barnidge, David R. ; Murray, David L. ; Dispenzieri, Angela ; Marin-Argany, Marta ; Dick, Christopher J. ; Cooper, Shawna A. ; Nasr, Samih H. ; Ward, Christopher J. ; Dasari, Surendra ; Jiménez-Zepeda, Víctor H. ; Leung, Nelson. / Assessment of renal response with urinary exosomes in patients with AL amyloidosis : A proof of concept. In: American Journal of Hematology. 2017 ; Vol. 92, No. 6. pp. 536-541.
@article{54a5ecbc22d743739547cb2df58f827f,
title = "Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept",
abstract = "Immunoglobulin light chain (AL) amyloidosis is a fatal complication of B-cell proliferation secondary to deposition of amyloid fibrils in various organs. Urinary exosomes (UEX) are the smallest of the microvesicles excreted in the urine. Previously, we found UEX of patients with AL amyloidosis contained immunoglobulin light chain (LC) oligomers that patients with multiple myeloma did not have. To further explore the role of the LC oligomers, UEX was isolated from an AL amyloidosis patient with progressive renal disease despite achieving a complete response. LC oligomers were identified. Mass spectrometry (MS) of the UEX and serum identified two monoclonal lambda LCs. Proteomics of the trypsin digested amyloid fragments in the kidney by laser microdissection and MS analysis identified a λ6 LC. The cDNA from plasma cell clone was from the IGLV- 6-57 family and it matched the amino acid sequences of the amyloid peptides. The predicted mass of the peptide product of the cDNA matched the mass of one of the two LCs identified in the UEX and serum. UEX combined with MS were able to identify 2 monoclonal lambda LCs that current clinical methods could not. It also identified the amyloidogenic LC which holds potential for response assessment in the future.",
author = "Marina Ramirez-Alvarado and Barnidge, {David R.} and Murray, {David L.} and Angela Dispenzieri and Marta Marin-Argany and Dick, {Christopher J.} and Cooper, {Shawna A.} and Nasr, {Samih H.} and Ward, {Christopher J.} and Surendra Dasari and Jim{\'e}nez-Zepeda, {V{\'i}ctor H.} and Nelson Leung",
year = "2017",
month = "6",
day = "1",
doi = "10.1002/ajh.24717",
language = "English (US)",
volume = "92",
pages = "536--541",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Assessment of renal response with urinary exosomes in patients with AL amyloidosis

T2 - A proof of concept

AU - Ramirez-Alvarado, Marina

AU - Barnidge, David R.

AU - Murray, David L.

AU - Dispenzieri, Angela

AU - Marin-Argany, Marta

AU - Dick, Christopher J.

AU - Cooper, Shawna A.

AU - Nasr, Samih H.

AU - Ward, Christopher J.

AU - Dasari, Surendra

AU - Jiménez-Zepeda, Víctor H.

AU - Leung, Nelson

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Immunoglobulin light chain (AL) amyloidosis is a fatal complication of B-cell proliferation secondary to deposition of amyloid fibrils in various organs. Urinary exosomes (UEX) are the smallest of the microvesicles excreted in the urine. Previously, we found UEX of patients with AL amyloidosis contained immunoglobulin light chain (LC) oligomers that patients with multiple myeloma did not have. To further explore the role of the LC oligomers, UEX was isolated from an AL amyloidosis patient with progressive renal disease despite achieving a complete response. LC oligomers were identified. Mass spectrometry (MS) of the UEX and serum identified two monoclonal lambda LCs. Proteomics of the trypsin digested amyloid fragments in the kidney by laser microdissection and MS analysis identified a λ6 LC. The cDNA from plasma cell clone was from the IGLV- 6-57 family and it matched the amino acid sequences of the amyloid peptides. The predicted mass of the peptide product of the cDNA matched the mass of one of the two LCs identified in the UEX and serum. UEX combined with MS were able to identify 2 monoclonal lambda LCs that current clinical methods could not. It also identified the amyloidogenic LC which holds potential for response assessment in the future.

AB - Immunoglobulin light chain (AL) amyloidosis is a fatal complication of B-cell proliferation secondary to deposition of amyloid fibrils in various organs. Urinary exosomes (UEX) are the smallest of the microvesicles excreted in the urine. Previously, we found UEX of patients with AL amyloidosis contained immunoglobulin light chain (LC) oligomers that patients with multiple myeloma did not have. To further explore the role of the LC oligomers, UEX was isolated from an AL amyloidosis patient with progressive renal disease despite achieving a complete response. LC oligomers were identified. Mass spectrometry (MS) of the UEX and serum identified two monoclonal lambda LCs. Proteomics of the trypsin digested amyloid fragments in the kidney by laser microdissection and MS analysis identified a λ6 LC. The cDNA from plasma cell clone was from the IGLV- 6-57 family and it matched the amino acid sequences of the amyloid peptides. The predicted mass of the peptide product of the cDNA matched the mass of one of the two LCs identified in the UEX and serum. UEX combined with MS were able to identify 2 monoclonal lambda LCs that current clinical methods could not. It also identified the amyloidogenic LC which holds potential for response assessment in the future.

UR - http://www.scopus.com/inward/record.url?scp=85018400814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018400814&partnerID=8YFLogxK

U2 - 10.1002/ajh.24717

DO - 10.1002/ajh.24717

M3 - Article

C2 - 28295502

AN - SCOPUS:85018400814

VL - 92

SP - 536

EP - 541

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 6

ER -